| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/27/2023 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Common Stock | 87.5k | $0.00 | $0 | | 07/27/2023 |
| 07/27/2023 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Common Stock | 12.5k | $0.00 | $0 | | 07/27/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Common Stock | 2.2k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 518 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 259 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 420 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 1000 | $0.00 | $0 | | 05/31/2023 |
| 06/16/2022 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 50k | $0.36 | $18k | | 06/16/2022 |
| 06/09/2022 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Nonstatutory Stock Option (right to buy) | 20k | $0.47 | $9.4k | | 06/09/2022 |
| 09/02/2021 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Nonstatutory Stock Option (right to buy) | 60k | $4.52 | $271.2k | | 09/02/2021 |
| 06/17/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 25k | $0.00 | $0 | | 06/17/2021 |
| 06/25/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 28k | $0.00 | $0 | | 06/25/2020 |
| 06/05/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 21k | $5.35 | $112.4k | | 06/05/2019 |
| 06/12/2018 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 13k | $13.73 | $177.9k | | 06/12/2018 |
| 06/04/2018 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 156.6k | $0.37 | $58.6k | | 06/04/2018 |
| 05/14/2018 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 14k | $0.52 | $7.3k | | 05/14/2018 |
| 03/19/2018 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 9.7k | $1.70 | $16.6k | | 03/19/2018 |
| 09/28/2017 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 25.9k | $23.08 | $598.2k | | 09/28/2017 |
| 06/05/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 161.9k | $1.28 | $207.1k | | 06/05/2017 |
| 05/11/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Employee Stock Option (right to buy) | 126.2k | $1.56 | $196.8k | | 05/11/2017 |
| 05/11/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Common Shares, without par value | 109.2k | $0.00 | $0 | | 05/11/2017 |
| 03/20/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 7.8k | $2.41 | $18.9k | | 03/20/2017 |
| 03/15/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Purchase | Common Shares, without par value | 20k | $2.55 | $50.9k | | 03/15/2017 |
| 06/03/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Payment of Exercise | Common Shares, without par value | 206.1k | $3.97 | $818.1k | | 06/03/2016 |
| 05/12/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Purchase | Common Shares, without par value | 71.5k | $3.49 | $249.5k | | 05/12/2016 |
| 03/17/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Common Shares, without par value | 62.1k | $0.00 | $0 | | 03/17/2016 |
| 03/17/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Stock Options (right to buy) | 52.6k | $3.80 | $199.8k | | 03/17/2016 |
| 02/05/2016 | Aralez Pharmaceuticals Inc. | ARLZ | Other (acquisition) | Common Shares | 1.5M | $0.00 | $0 | | 02/05/2016 |
| 06/03/2015 | POZEN INC /NC | POZN | Grant | | 1.5M | $0.00 | $0 | | 06/03/2015 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 16.3k | $0.00 | $0 | | 02/07/2013 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 6.4k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 6.4k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Payment of Exercise | Common Stock | 623 | $28.30 | $17.6k | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Common Stock | 16.3k | $0.00 | $0 | | 02/18/2014 |
| 02/18/2014 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Nonqualified Stock Option (Right to Buy) | 40.6k | $28.30 | $1.1M | | 02/18/2014 |
|